CareersFind a DoctorMake an AppointmentDepartmentsDirections & ParkingGiftsContact UsPRINT

	Comprehensive Cancer Center   Director's Message   Types of Cancer   Integrated Brachytherapy   Clinical Trials   Centers of Excellence   Breast Care Center   Cancer Patient Support   Patient Information   Videos and Webcasts   Research   Additional Cancer Resources   Areas of Focus   Departments   Research Base   Accruals   Adverse Events DSMB   Annual Meeting   Links   Newsletter   Patient Registration   Protocols   Protocols   Quick Reference Guides   Results   Sites   Staff   Welcome   Virtual Tours   Cancer Center Map   Friends of the Center   How You Can Help		WFUBMC Home   >    Comprehensive Cancer Center   >    Research Base   >    Protocols   >    71103   >    71103 71103 A Phase II Study of Single Agent Depsipeptide (FK228) in Metastatic or Unresectable Soft Tissue Sarcomas   This study is closed to patient accrual as of 5/20/2008.  Please contact the Research Base Protocol Information Office if you have any questions. Appendices  l  Archived Amendments  l  Adverse Events   CCCWFU CCOP Research Base Home  l  Protocols  l  Welcome  l  Patient Registration  l  Accruals    Annual Meeting  l  Results  l  Adverse Events  l  Newsletter    Quick Reference Guides  l  Links  l  Sites  l  Staff  l  Contact Us

[Website Access Agreement] [Privacy Notices] [Copyright Information] [Campus Security Act]
Copyright: Wake Forest University School of Medicine and North Carolina Baptist Hospitals. All rights reserved.
Medical Center Boulevard
Winston-Salem, NC 27157
The information on this Website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified healthcare provider. If you have a medical problem or a health-related question, consult your physician or call Health On-Call at 336-716-2255 or 1-800-446-2255.
Send Feedback	Home	Site Index
	Last Modified: 5/29/2008